KRAS and pancreatic neoplasm: As reported, growth of KRAS mutant pancreatic cancer cells with targeted inactivation of PIK3CA, a parallel branch of the KRAS signaling pathway, is also inhibited in syngeneic wild-type mice but not in nude mice due to the upregulation of MHC class I expression58.